BRII BIOSCIENCES L
(HKEX: 2137)
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
1.600 -
-0.030
(-1.84%)
Range
1.580 - 1.630
(3.16%)
Open
1.620
Previous Close
1.630
Bid Price
1.590
Bid Volume
('000)
20
Ask Price
1.600
Ask Volume
('000)
3.5
Volume
('000)
1,949
Value
3,120,235
Remark
-
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
